Entera Bio Ltd. ( ENTX) - Stock Earnings
ENTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
ENTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.0 million USD | — USD |
| 2026Q1 | -3.5 million USD | — USD |
| 2026Q2 | -7.3 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ENTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.9 million USD | 14000 USD |
| 2024 | -9.5 million USD | 181000 USD |
| 2025 | -11.4 million USD | 42000 USD |
| 2026 Est. | — | — |
ENTX
Price: $2.72
52 week price:
Earnings Per Share: -0.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 1891
Market Capitalization: 124.7 million